The short answer

Standard drug panels don't test for muscimol or psilocybin. But many mushroom products contain hemp-derived THC, which will trigger the marijuana line.

What standard tests detect

Federal workplace panels screen for marijuana metabolite, cocaine, amphetamines, opioids, PCP, and fentanyl. That's the complete list as of July 2025.

Mushroom compounds aren't on panels

Nothing on standard drug tests detects muscimol or psilocybin. Pure Amanita extract or functional blends like lion's mane have no target on the sheet.

Psilocybin tests exist but are rare

Labs can test for psilocin with specialty orders using mass spectrometry. It takes seven to fourteen days and must be requested and paid for separately.

No routine muscimol test exists

There aren't even recognized testing standards for muscimol concentration in products, let alone in people, according to a 2026 review.

The THC blend problem

Many mushroom gummies pair extract with delta-9 THC. Disposables often carry THCA, delta-8, or THC-P alongside muscimol, and all of these trigger tests.

“Whether a mushroom gummy shows up on a drug test therefore has almost nothing to do with the mushroom and everything to do with what was blended into it.”

How THC blends get detected

Delta-9 THC breaks down into carboxy-THC, the metabolite every marijuana test hunts. Heated THCA becomes delta-9 THC, ending up in the same place.

Check the lab report

Read the certificate of analysis, not the flavor name. A THC-free product should show a cannabinoid panel with non-detect results for all THC compounds.

Detection windows for THC

THC metabolite is fat-soluble and clears slowly, giving cannabis the longest detection windows on standard panels compared with most drug classes.

The practical rule

Muscimol-only products don't register on tests. THC blends do. The word mushroom on the label tells you nothing about which one you have.

“The only way a mushroom product fails a test is by containing something the panel already hunts.”